CC Neuberger Plans Shareholder Vote on E2open Merger

The SPAC completed a $200 million IPO in March 2022. Since then, it has focused on life sciences targets based in Asia. Valuence I has yet to announce a deal.

The SPAC raised $220 million in an April 2021 IPO "to focus on the rapidly growing universe of Israeli companies and entrepreneurs that apply technology and innovation to our everyday lives,” according to the S-1 filing.

Marblegate will focus on companies that have undergone restructuring.